CellaVision AB Earnings, Revenue miss in Q3
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CellaVision AB (0MR5)
Assess today's live CellaVision AB (CEVI) share price, performance and insights using our live Stockholm: CEVI stock exchange data.
Analyse the historical data and CellaVision AB share price performance charts on this page. Our technical summary section provides analysis on CellaVision AB share price buy/sell indicators using real-time data (or discuss the CellaVision AB (CEVI) stock price today with other investors in the CellaVision AB ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST CEVI share price (ISIN: SE0000683484) to enhance your trading decisions with our free investment tools and resources.
What Is the CellaVision AB Share Price Today?
The CellaVision AB share price today is 209.25.
What Is the Stock Symbol for CellaVision AB
The stock symbol (or 'ticker') for CellaVision AB is "CEVI."
What Stock Exchange Does CellaVision AB Trade On?
CellaVision AB is listed and trades on the Stockholm stock exchange.
Is CellaVision AB a Good Stock to Buy?
Determining whether CellaVision AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and CellaVision AB share price performance charts on this page. Our technical summary section provides analysis on CellaVision AB share price buy/sell indicators using real-time data (or discuss the CellaVision AB (CEVI) stock price today with other investors in the CellaVision AB ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST CEVI share price (ISIN: SE0000683484) to enhance your trading decisions with our free investment tools and resources.
What Is the CellaVision AB Share Price Today?
The CellaVision AB share price today is 209.25.
What Is the Stock Symbol for CellaVision AB
The stock symbol (or 'ticker') for CellaVision AB is "CEVI."
What Stock Exchange Does CellaVision AB Trade On?
CellaVision AB is listed and trades on the Stockholm stock exchange.
Is CellaVision AB a Good Stock to Buy?
Determining whether CellaVision AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
209.25
+4.50(+2.15%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
209.00
212.00
52 wk Range
186.50
303.00
0MR5 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
209.00212.00
52 wk Range
186.50303.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
0MR5 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
CellaVision AB Company Profile
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a web-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, the company offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.
Compare 0MR5 to Peers and Sector
Metrics to compare | 0MR5 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0MR5PeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.7x | −0.9x | −0.6x | |
PEG Ratio | 0.98 | −0.02 | 0.00 | |
Price/Book | 6.6x | 2.4x | 2.6x | |
Price / LTM Sales | 6.9x | 2.7x | 3.1x | |
Upside (Analyst Target) | - | 20.0% | 55.2% | |
Fair Value Upside | Unlock | 25.7% | 9.8% | Unlock |
Earnings
Latest Release
Oct 24, 2024
EPS / Forecast
1.30 / 1.30
Revenue / Forecast
179.00M / 179.00M
People Also Watch
FAQ
What Is the CellaVision AB (0MR5) Stock Price Today?
The CellaVision AB stock price today is 209.25
What Stock Exchange Does CellaVision AB Trade On?
CellaVision AB is listed and trades on the London stock exchange.
What Is the Stock Symbol for CellaVision AB?
The stock symbol for CellaVision AB is "0MR5."
Does CellaVision AB Pay Dividends? What’s The Current Dividend Yield?
The CellaVision AB dividend yield is 1.06%.
What Is the CellaVision AB Market Cap?
As of today, CellaVision AB market cap is 5.07B.
What is CellaVision AB Earnings Per Share?
The CellaVision AB EPS is 6.30.
What Is the Next CellaVision AB Earnings Date?
CellaVision AB will release its next earnings report on 06 Feb 2025.
From a Technical Analysis Perspective, Is 0MR5 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.